Equities

Regencell Bioscience Holdings Ltd

RGC:NAQ

Regencell Bioscience Holdings Ltd

Actions
  • Price (USD)6.33
  • Today's Change-0.18 / -2.76%
  • Shares traded65.00
  • 1 Year change-48.95%
  • Beta--
Data delayed at least 15 minutes, as of Sep 19 2024 20:58 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.

  • Revenue in USD (TTM)0.00
  • Net income in USD-4.71m
  • Incorporated2014
  • Employees12.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Omega Therapeutics Inc6.31m-78.90m78.32m93.00--2.98--12.40-1.43-1.430.11450.47620.0318--6.6767,892.48-39.72---46.68-------1,249.54------0.3917--49.25--5.13------
IO Biotech Inc0.00-88.00m78.40m68.00--0.8143-----1.44-1.440.001.460.00----0.00-76.85---86.10--------------0.00-------20.47------
Chimerix Inc144.00k-84.70m78.43m72.00--0.5041--544.68-0.9507-0.95070.00161.740.0007--1.862,000.00-40.37-30.45-44.33-34.0910.42---58,820.14-442.93----0.00---99.04-46.24-147.68---13.24--
Sellas Life Sciences Group Inc0.00-34.44m78.49m16.00--24.19-----0.934-0.9340.000.05040.00----0.00-204.48-111.48-838.03-184.29-------1,289.42----0.00---100.00--9.59------
Renovaro Inc0.00-88.12m79.21m11.00--0.4698-----1.08-1.080.001.140.00----0.00-60.56-27.81-68.21-28.44-----------24.380.0405------65.02---0.1538--
Armata Pharmaceuticals Inc3.72m-67.04m80.69m66.00------21.70-1.95-1.950.0893-1.280.0355--0.753256,348.48-64.00-59.78-385.50-72.70-----1,802.72-1,113.72---1.991.71---17.77---87.03--184.10--
Vistagen Therapeutics Inc970.40k-33.19m81.17m41.00--0.7745--83.64-1.53-1.530.03863.870.0151----24,882.05-51.63-62.84-56.12-68.03-----3,420.44-5,768.52----0.00--568.10--50.44---18.91--
Genelux Corp8.00k-26.54m81.85m23.00--2.14--10,231.13-0.9704-0.97040.00031.110.0002----347.83-69.34---84.43-------331,725.00------0.00---98.46---443.44------
Regencell Bioscience Holdings Ltd0.00-4.71m82.37m12.00--8.11-----0.362-0.3620.000.7810.00----0.00-37.91---37.91--------------0.00------21.15------
Cidara Therapeutics Inc31.58m-116.17m82.49m69.00--0.409--2.61-25.49-25.306.9528.660.2617--8.06457,623.20-96.27-65.23-136.45-154.3791.14---367.91-100.61----0.0053---0.8425--31.72--23.33--
Milestone Pharmaceuticals Inc0.00-48.41m82.57m47.00--2.58-----1.01-1.010.000.60030.00----0.00-51.98-48.44-55.36-51.56-------1,267.25----0.6171---80.00---2.22--86.23--
Medicinova Inc1.00m-8.16m82.89m13.00--1.44--82.89-0.1665-0.16650.02041.170.0155----76,923.08-12.65-15.36-13.19-15.90-----816.49-1,182.54----0.00------39.08--15.87--
Ovid Therapeutics Inc567.53k-29.75m83.04m40.00--0.934--146.31-0.4218-0.42180.0081.250.0045----14,188.25-23.39-20.78-25.86-23.27-----5,241.56-56.16----0.00---73.93--3.38---17.14--
Bioatla Inc0.00-104.56m84.10m65.00--2.68-----2.18-2.180.000.64910.00----0.00-84.23-48.72-106.06-57.35-------6,651.71----0.00-------15.95---37.01--
Aclaris Therapeutics Inc32.02m-58.68m86.33m91.00--0.645--2.70-0.8267-0.82670.45091.880.1614--84.70351,824.20-29.58-47.29-32.76-53.8742.6344.00-183.28-549.18----0.00--5.0338.41-1.81---0.703--
Data as of Sep 19 2024. Currency figures normalised to Regencell Bioscience Holdings Ltd's reporting currency: US Dollar USD

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
UBS Securities LLCas of 30 Jun 2024312.000.00%
BlackRock Financial Management, Inc.as of 30 Jun 2024238.000.00%
Qube Research & Technologies Ltd.as of 30 Jun 202413.000.00%
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.